Search

everythinglearnresearchcommunity

for

Search:↓

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Alopecia areata is caused by the immune system attacking hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

JAK inhibitors might help treat alopecia areata.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.